Navigation Links
NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect
Date:5/12/2008

IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- NuRx Pharmaceuticals, Inc. (OTC Bulletin Board: NURX pre split, NUXP post split) today announced that on May 9th, the Company's 1-for-4 reverse stock split became effective. The Company has been informed by the Over The Counter Bulletin Board's Corporate Actions group that, in connection with the reverse stock split, its trading symbol has changed from NURX to NUXP.

The reverse stock split will reduce the number of issued and outstanding shares of NuRx's common stock from approximately 129.5 million shares (on a fully diluted basis) to approximately 34.3 million shares.

NuRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of next-generation retinoid and rexinoid compounds for application in oncology (treatment, prevention and adjunctive supportive therapy) and other highly prevalent diseases. The company's lead compounds are NRX5183, an RAR agonist for the treatment of acute leukemia, and NRX4204, a highly specific, next-generation rexinoid agonist that is targeted for development in non-small cell lung carcinoma and breast cancer. Based in Irvine, Calif., NuRx has a technology and IP platform that includes a library of nearly 6,000 compounds supported by 230 issued U.S. and international patents and more than 80 additional patents in application. For more information, visit http://www.nurxpharmaceuticals.com.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this news release, all forward-looking statements are predictions by the Company's management and are subject to various ri
'/>"/>

SOURCE NuRx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amylin Pharmaceuticals to Present at Baird Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
3. Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
4. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
5. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
7. Onyx Pharmaceuticals to Present at Bank of America Health Care Conference
8. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
9. VIA Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008
11. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ec. 2 Peregrine Pharmace...letion of patient enrollment in a dose confirmatio...with relapsed glioblastoma multiforme (GBM), the d...ed monoclonal antibody linked to a radioisotope be.... Cotara specifically targets cells at the center...
(Date:12/2/2009)..., Israel, December 2 Gamida Cell a...preclinical (animal study) safety and,efficacy of ...rom Weill,Cornell Medical College and Gamida Cell.... anemias such as Cooley,s Anemia. , Gamid...xpand, ex vivo,populations of stem/progenitor cel...
(Date:12/2/2009).... 2 /PRNewswire-Asia/ -- The world is going throug...uncertainty is part of many,businesses and industr...n,relatively immune to the economic downturn, beca...ring the midst of the difficult times this year, t...gurated an R&D center in Shanghai, the largest...
(Date:12/1/2009)... 1 Reportlinker.com announces that...catalogue: ,, Chromium - Global Market Trends...omium---Global-Market-Trends.html ,, Worldwide...ainless steel, while growth in aerospace and indus...owth of chromium metal. Environmental constraints ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...h,Corporation (NYSE: SGP ) today announced the su...action with Virbac, S.A. to divest animal health,p...s were requested by the,European Commission as par... of Organon BioSciences N.V., In Europe, Virbac a...sulphonamide franchises of Intervet/Schering-Ploug...
...drenex,Pharmaceuticals set it sights on building a...," the small Durham company has signed its second ...elop a new compound for,hypertension and other pot...he hormone that triggers the "fight or,flight" rea...cientists,recognized this hormone, and its counter...
...y,Innovation Network (DVIN) announced today the aw...Wistar Institute will receive $89,000 to support t...gram, a two-year workforce,development program in ...rogram provides Community College of Philadelphia ... training while preparing for,careers as Biomedica...
Other Biology Technology:Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications 2Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute 2Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute 3
(Date:12/2/2009)...-American adolescents exposed to cigarette smoking...abit themselves, and this may be part of the accul...n, according to new study findings. , "Our study...ates and highlights the global implementation of t...on Tobacco Control, which includes guidelines for ...
(Date:12/2/2009)...9572; A Smoky Mountain forest,s woodland herb popu...ow forest understories recover from logging, accor...avy logging in portions of the forest nearly 80 ye...e secondary forest floor was similar to that of un...nt professor of forestry and natural resources, sa...
(Date:12/2/2009)...sed of undergraduate students from Stevens Institu...nal poster contest hosted by the International Soc...e annual contest highlights the research conducted...PE Annual Meeting in San Diego, Calif. , The win...ciate Ligament Tensioning Device," was presented b...
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2Richard T Crowder Joins Neogens Board of Directors 14944 1Richard T Crowder Joins Neogens Board of Directors 14944 2Lexicon to Present Positive Top Line Phase 2 Results for LX1031 in Non Constipating Irritable Bowel Syndrome at GASTRO 2009 6466 1Lexicon to Present Positive Top Line Phase 2 Results for LX1031 in Non Constipating Irritable Bowel Syndrome at GASTRO 2009 6466 2Lexicon to Present Positive Top Line Phase 2 Results for LX1031 in Non Constipating Irritable Bowel Syndrome at GASTRO 2009 6466 3Reported Use of AMAGs Feraheme 28ferumoxytol 29 Continues To Be Low But a Number of Nephrologists Are On the Verge of Use 6464 1Reported Use of AMAGs Feraheme 28ferumoxytol 29 Continues To Be Low But a Number of Nephrologists Are On the Verge of Use 6464 2
...in a western or southeastern state can pump as muc...s as the state,s entire motor vehicle traffic does...by scientists at the National Center for Atmospher...at Boulder. , The paper, "Estimates of CO2 from f... management," is being published online today in t...
... 1st and November 15th issues of Biophysical Journ...available online. Topics of interest include volt...synthetic drug design, the absence of large lipid ...porter dimmer. , Volume 93, Issue 9, November 1... channel in a Membrane Environment , Vishwanath Jo...
...des on a pair of plastic 3-D glasses and an uneart...t of a sci-fi horror flick -- seems to leap out of...his is no movie director,s fantasy. The horror ima...adly anthrax bacteria -- specifically one of its p...einberg School of Medicine are mapping parts of th...
Other Biology News:US fires release large amounts of carbon dioxide 2US fires release large amounts of carbon dioxide 3Media highlights in the November issues of Biophysical Journal 2Media highlights in the November issues of Biophysical Journal 3Northwestern to expose most deadly infectious diseases in 3-D 2Northwestern to expose most deadly infectious diseases in 3-D 3Northwestern to expose most deadly infectious diseases in 3-D 4
Mouse Anti-Human ZNF155 Monoclonal Antibody, Unconjugated, Clone 2F11 from Abnova Corporation
Mouse Anti-Human COASY Polyclonal Antibody, Unconjugated from Abnova Corporation
Rabbit Anti-Nonmuscle Myosin II Heavy Chain B (MHC-B) Polyclonal Antibody, Unconjugated from Covance Research Products, Inc
...educed and non-reduced forms. It does not react wi...Factor XIII is a Beta-globulin found in plasma and... catalytic subunit and is a dimmer of M.W. 160kDa....2 heterodimer (M.W. 320kDa); whereas in platelets,...
Biology Products: